We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Co-Diagnostics, Inc.

Co-Diagnostics, Inc. is a molecular diagnostics company that develops, manufactures and markets a new, state-of-the-a... read more Featured Products: More products

Download Mobile App





Co-Diagnostics Introduces Co-Dx PCR Platform and Co-Primers Technology

By LabMedica International staff writers
Posted on 11 Nov 2024
Print article
Image: The Co-Dx PCR testing platform highlighted at MEDICA 2024 aims to provide accessible, affordable PCR testing for all (Photo courtesy of Co-Diagnostics)
Image: The Co-Dx PCR testing platform highlighted at MEDICA 2024 aims to provide accessible, affordable PCR testing for all (Photo courtesy of Co-Diagnostics)

Co-Diagnostics (Salt Lake City, UT, USA), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, is hosting a booth and delivering a presentation at the MEDICA 2024 trade fair in Düsseldorf. MEDICA has become the world's largest medical B2B trade fair, attracting 83,000 visitors and over 5,300 exhibitors from almost 70 countries. The company aims to use the opportunity to generate increased interest in its suite of PCR in vitro diagnostic and research products for infectious diseases and to introduce and promote its Co-Primers technology and applications to a wide audience of international attendees.

Co-Primers by Co-Diagnostics is a new class of primer technology that uses a novel architecture to help combat some common issues that can plague multiplex PCR. The unique Co-Primers design reduces primer dimer propagation. Co-Primers technology includes the use of cooperative primers sometimes in combination with other types of primers or probe designs, and is the first PCR technology of its kind to help prevent primer dimer propagation during nucleic acid amplification. In multiplexed reactions where large numbers of primers increase the probability of primer dimer formation, enhanced specificity is particularly important. In a traditional primer process, a pair of primers hybridizes with the sample DNA or RNA sequence and defines the region that will be amplified. In a Co-Primers process, the PCR primer is divided into two segments separated by a PEG (polyethylene glycol) linker. Both the capture sequence and the priming sequence must cooperate to bind to the DNA or RNA target to amplify the intended region. Primer dimers are not propagated because they cannot hybridize to the capture region.

The company's presentation on its upcoming Co-Dx PCR platform is titled "Advancing POC/OTC Diagnostics: Innovations in Test Development for the Co-Dx PCR Platform". The Co-Dx PCR testing platform aims to provide accessible, affordable PCR testing for all, transforming healthcare delivery and creating a positive impact on a global scale by democratizing access to molecular diagnostics. The instrument with dimensions of 6 ½” x 4 1/2” x 6” and weighing two pounds operates via a smartphone app with simple-to-follow instructions that include videos to walk users through every step, some sample swab collection to the straightforward instrument operation. Results are processed in the cloud and delivered back to the user’s smartphone or tablet in about 30 minutes using software designed from the ground up for this specific use. The PCR tests themselves (contained in the simple but unique, innovative test collection cups) are powered by Co-Primers PCR technology.

Related Links:
Co-Diagnostics

Gold Member
Turnkey Packaging Solution
HLX
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Histamine ELISA
Histamine ELISA
New
Rocking Shaker
HumaRock

Print article

Channels

Hematology

view channel
Image: Personalized blood count could lead to early intervention for common diseases (Photo courtesy of 123RF)

Personalized CBC Testing Could Help Diagnose Early-Stage Diseases in Healthy Individuals

A complete blood count (CBC) screening is a standard examination most physicians request for healthy adults. This test is essential for evaluating a patient’s overall health with a single blood sample.... Read more

Immunology

view channel
Image: Concept for the device. Memory B cells able to bind influenza virus remain stuck to channels despite shear forces (Photo courtesy of Steven George/UC Davis)

Microfluidic Chip-Based Device to Measure Viral Immunity

Each winter, a new variant of influenza emerges, posing a challenge for immunity. People who have previously been infected or vaccinated against the flu may have some level of protection, but how well... Read more

Microbiology

view channel
Image: The BIOFIRE® FILMARRAY® Tropical Fever Panel has received U.S. FDA Special 510(k) clearance (Photo courtesy of bioMérieux)

Syndromic PCR Test Rapidly and Accurately Identifies Pathogens in Patients with Tropical Fever Infections

Tropical fevers refer to infections that are common in, or unique to, tropical and subtropical regions. As these diseases spread to previously unaffected areas and can be brought in by travelers, infections... Read more

Pathology

view channel
Image: The new study highlights efficiency in detecting infectious diseases (Photo courtesy of Adobe Stock)

Optimized Pooled Testing Approach Could Transform Public Health Screening for Infectious Diseases

Traditional individual testing methods can be resource-intensive, particularly when it comes to large-scale screenings. Pooled testing, on the other hand, enables the testing of multiple specimens together,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.